Mother and son jogging Mother and son jogging Mother and son jogging Mother and son jogging
Advanced Search
  • Dec 17, 2020
    - Abbott's HeartMate 3™ heart pump approved for use for pediatric patients battling advanced heart failure
    - This life-saving technology provides new treatment option for underserved population
  • Dec 16, 2020
    - First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes
    - Abbott and eMed™ expect to deliver and administer 30 million BinaxNOW™ tests in the first quarter of 2021, with an additional 90 million in the second quarter
    - $25 cost for the test and service is the lowest available for at-home testing, which supports the home user to ensure a successful testing process
    - BinaxNOW is a highly portable, easy-to-use, 15-minute antigen test with no instrument that detects the virus when people are most infectious, which is critically important in slowing the spread of the virus
    - Service uses Abbott's complementary NAVICA™ app to enable the testing process and display authenticated BinaxNOW test results verified by a trained guide - and supports consumer confidence in testing at home
  • Dec 15, 2020
    - SARS-CoV-2 IgG II Quant antibody test measures levels of IgG antibodies to help measure and understand a person's immune response
    - The test specifically identifies levels of IgG antibodies that attach to the virus' spike protein which can be helpful to evaluate a person's immune response to vaccines
    - CE Mark test will be available for use on Abbott's ARCHITECT® and Alinity i™ platforms
    - Abbott plans to submit its test for U.S. Food and Drug Administration (FDA) emergency use authorization soon
  • Dec 14, 2020
    - New product contains zinc, prebiotics and vitamins B12, C and E
    - Abbott expands its Pedialyte product portfolio with four new product introductions: Pedialyte with Immune Support, Pedialyte Sport, Pedialyte Organic and Pedialyte Electrolyte Water with Zero Sugar
  • Dec 11, 2020
    - Increase reflects strength and sustainability of Abbott's diversified business
    - Dividend increased for 49th consecutive year
    - Abbott remains an S&P 500 Dividend Aristocrat
Show 5102550100 per page
true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?